PLOS Digital Health (Jul 2024)

Geographical validation of the Smart Triage Model by age group.

  • Cherri Zhang,
  • Matthew O Wiens,
  • Dustin Dunsmuir,
  • Yashodani Pillay,
  • Charly Huxford,
  • David Kimutai,
  • Emmanuel Tenywa,
  • Mary Ouma,
  • Joyce Kigo,
  • Stephen Kamau,
  • Mary Chege,
  • Nathan Kenya-Mugisha,
  • Savio Mwaka,
  • Guy A Dumont,
  • Niranjan Kissoon,
  • Samuel Akech,
  • J Mark Ansermino,
  • Pediatric Sepsis CoLab

DOI
https://doi.org/10.1371/journal.pdig.0000311
Journal volume & issue
Vol. 3, no. 7
p. e0000311

Abstract

Read online

Infectious diseases in neonates account for half of the under-five mortality in low- and middle-income countries. Data-driven algorithms such as clinical prediction models can be used to efficiently detect critically ill children in order to optimize care and reduce mortality. Thus far, only a handful of prediction models have been externally validated and are limited to neonatal in-hospital mortality. The aim of this study is to externally validate a previously derived clinical prediction model (Smart Triage) using a combined prospective baseline cohort from Uganda and Kenya with a composite endpoint of hospital admission, mortality, and readmission. We evaluated model discrimination using area under the receiver-operator curve (AUROC) and visualized calibration plots with age subsets (< 30 days, ≤ 2 months, ≤ 6 months, and < 5 years). Due to reduced performance in neonates (< 1 month), we re-estimated the intercept and coefficients and selected new thresholds to maximize sensitivity and specificity. 11595 participants under the age of five (under-5) were included in the analysis. The proportion with an endpoint ranged from 8.9% in all children under-5 (including neonates) to 26% in the neonatal subset alone. The model achieved good discrimination for children under-5 with AUROC of 0.81 (95% CI: 0.79-0.82) but poor discrimination for neonates with AUROC of 0.62 (95% CI: 0.55-0.70). Sensitivity at the low-risk thresholds (CI) were 85% (83%-87%) and 68% (58%-76%) for children under-5 and neonates, respectively. After model revision for neonates, we achieved an AUROC of 0.83 (95% CI: 0.79-0.87) with 13% and 41% as the low- and high-risk thresholds, respectively. The updated Smart Triage performs well in its predictive ability across different age groups and can be incorporated into current triage guidelines at local healthcare facilities. Additional validation of the model is indicated, especially for the neonatal model.